Dr. Salim Dhanji reports

ME THERAPEUTICS HOLDINGS INC. ANNOUNCES LISTING ON THE FRANKFURT STOCK EXCHANGE (FSE) AND THE COMPLETION OF ITS REDESIGNED WEBSITE

ME Therapeutics Holdings Inc.'s common shares are now listed on the Frankfurt Stock Exchange (FSE) under the symbol Q9T.

"Listing on the Frankfurt Stock Exchange is an important step for the company, as it provides us with an opportunity to expand our investor base to Europe and provide greater liquidity while we continue to develop our novel myeloid-cell-focused immuno-oncology drug candidates," said Dr. Salim Dhanji, PhD, chief executive officer.

The Frankfurt Stock Exchange is one of the world's largest trading centres for securities and is the largest exchange in Germany. The FSE facilitates advanced electronic trading, settlement and information systems, and enables cross-border trading for international investors.

The redesign of the company's website is now complete and the site is now live. The new website provides a user-friendly place for investors to access information about the company and its research programs.

About ME Therapeutics Holdings Inc.

ME Therapeutics Holdings is an early-stage, Vancouver-based biotechnology company involved in the discovery and development of novel immuno-oncology therapeutics targeting immune suppression in cancer. The company's main focus is on overcoming the suppressive effects of an important class of immune cells called myeloid cells in order to enhance anti-cancer immunity.

We seek Safe Harbor.